Summit Therapeutics Stock (NASDAQ:SMMT), Quotes and News Summary

Q: What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Summit Therapeutics Stock (NASDAQ: SMMT) stock price, news, charts, stock research, profile.

Open	$3.630
Close	-
Volume / Avg.	697.834K / 2.205M
Day Range	3.520 - 3.875
52 Wk Range	1.300 - 5.220
Market Cap	$2.547B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	26.19%
Days to Cover	7.71

Recent News

Director of Lululemon Purchases Shares After Large Drop – Insider Weekends

Key Insights:

Asif Suria

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

Avi Kapoor

Akeso Marks Profit Milestone With Swift Rights Issue

Key Takeaways: Akeso swung to an annual profit of 1.94 billion yuan, boosted by licensing income of 2.92 billion yuan The next highly anticipated product in the firm’s drug pipeline is ivonescimab, the first PD-1/VEGF bispecific antibody to enter Phase III clinical trials By Molly Wen

The Bamboo Works

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Summit Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Summit Therapeutics (SMMT) stock?

You can purchase shares of Summit Therapeutics (NASDAQ: SMMT) through any online brokerage.

View our list of the best stock brokerages.

Who are Summit Therapeutics's (SMMT) competitors?

Other companies in Summit Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX), TG Therapeutics (NASDAQ:TGTX) and Arrowhead Pharma (NASDAQ:ARWR).

What is the target price for Summit Therapeutics (SMMT) stock?

The latest price target for Summit Therapeutics (NASDAQ: SMMT) was reported by Stifel on Tuesday, March 26, 2024. The analyst firm set a price target for 8.00 expecting SMMT to rise to within 12 months (a possible 108.06% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Summit Therapeutics (SMMT)?

The stock price for Summit Therapeutics (NASDAQ: SMMT) is $3.845 last updated Today at April 26, 2024 at 3:04 PM EDT.

Does Summit Therapeutics (SMMT) pay a dividend?

There are no upcoming dividends for Summit Therapeutics.

When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?

Summit Therapeutics’s Q1 earnings are confirmed for Wednesday, May 1, 2024.

Is Summit Therapeutics (SMMT) going to split?

There is no upcoming split for Summit Therapeutics.

What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-